Dr. Reddy’s jumped 3% after it teamed up with Iceland-based Alvotech to make a copy of cancer drug Keytruda.
Keytruda is an advanced drug used to treat multiple cancers including lung cancer, skin cancer (melanoma), and blood cancers like Hodgkins lymphoma by helping the body’s immune system attack tumour cells.
The deets: through this collaboration, both the companies will co-develop, manufacture, and commercialise Keytruda biosimilar.
The goal is here to speed up development and take the biosimilar global.
Zoom out: immune-based cancer therapies are seeing a boom. Biosimilars like this could expand access to cutting-edge treatment for cancers that were once hard to manage.
